The role of the cytoplasmic domain of the human immunodeficiency virus type 1 (HIV-1) envelope glycoproteins in virus replication was investigated. Deletion of residues 840 to 856 at the carboxyl terminus of gp4l reduced the efficiency of virus entry during an early step in the virus life cycle between CD4 binding and formation of the DNA provirus without affecting envelope glycoprotein synthesis, processing, or syncytiumforming ability. Deletion of residues amino terminal to residue 846 was associated with decreased stability of envelope glycoproteins made in COS-1 cells, but this phenotype was cell type dependent. The cytoplasmic domain of gp4l was not required for the incorporation of the HIV-1 envelope glycoproteins into virions. These results suggest that the carboxyl terminus of the gp4l cytoplasmic domain plays a role in HIV-1 entry other than receptor binding or membrane fusion. The cytoplasmic domain of gp4l also affects the stability of the envelope glycoprotein in some cell types.
The role of the cytoplasmic domain of the human immunodeficiency virus type 1 (HIV-1) envelope glycoproteins in virus replication was investigated. Deletion of residues 840 to 856 at the carboxyl terminus of gp4l reduced the efficiency of virus entry during an early step in the virus life cycle between CD4 binding and formation of the DNA provirus without affecting envelope glycoprotein synthesis, processing, or syncytiumforming ability. Deletion of residues amino terminal to residue 846 was associated with decreased stability of envelope glycoproteins made in COS-1 cells, but this phenotype was cell type dependent. The cytoplasmic domain of gp4l was not required for the incorporation of the HIV-1 envelope glycoproteins into virions. These results suggest that the carboxyl terminus of the gp4l cytoplasmic domain plays a role in HIV-1 entry other than receptor binding or membrane fusion. The cytoplasmic domain of gp4l also affects the stability of the envelope glycoprotein in some cell types.
The presence of a long intracytoplasmic domain at the carboxyl terminus of the gp4l transmembrane protein of the human immunodeficiency virus type 1 (HIV-1) distinguishes the HIV-1 envelope glycoprotein from that of most retroviruses (4, 12, 34) . The transmembrane proteins of the type C and type D retroviruses terminate within 50 amino acids carboxy terminal to the transmembrane domain (34) . The presence of a cytoplasmic domain extending more than 100 amino acids beyond the transmembrane region in HIV-1, the simian immunodeficiency virus (SIV), visna virus, and the equine infectious anemia virus suggests a specific function for this region in the life cycle of the lentivirus subfamily of retroviruses (12, 34) . HIV-2 and SIV are frequently truncated just after the membrane anchor domain, but these truncated forms appear to result from selection during tissue culture propagation in human cells (4, 19, 20, 22) . The natural form of the SIV transmembrane protein is the full-length 41-kDa protein (20, 22) .
The HIV-1 envelope glycoprotein is initially made as a 160-kDa glycosylated precursor that is cleaved to form the gpl20 exterior and gp4l transmembrane subunits (7, 8, 40) . The gpl20 glycoprotein determines the tropism of HIV-1 for specific target cells by binding to the CD4 molecule (6, 21, 27) . The gp4l transmembrane glycoprotein contains an extracellular domain that is required for membrane fusion and noncovalent association with the gpl20 glycoprotein, a hydrophobic transmembrane region that anchors the gpl20-gp4l complex in the cell or virion lipid bilayer, and an intracytoplasmic domain of unknown function (2, 11, 14, 24, 35) . The cytoplasmic domain contains two highly conserved segments with the potential to form amphipathic ao helices and may form a secondary association with the lipid bilayer (1, 14, 15, 39) .
The cytoplasmic domain of gp4l is required for efficient HIV-1 replication, but the function of this domain in the virus life cycle is unknown (9, 26, 37) . The cytoplasmic domain is not required for syncytium formation or binding to CD4 (7, 8, 24) but may modulate intracellular transport and processing of gpl60 in some cell types (16) . Whether the cytoplasmic domain is involved in virion assembly, for example, by facilitating the incorporation of envelope glycoproteins into virions, is unknown.
To investigate the role of the gp41 cytoplasmic domain in virus replication, the effect of deletions in this region on the synthesis, processing, cell surface expression, incorporation into virions, and biological function of the HIV-1 envelope glycoproteins was investigated.
MATERIALS AND METHODS
Plasmids. The pSVIIIenv plasmid expresses the HIV-1 env and rev genes of the HXB2 strain (31) under the control of the HIV-1 long terminal repeat (LTR) (17, 24) . The pHXBAenvCAT plasmid contains an HIV-1 provirus with an in-frame deletion from the BglII to BglII sites (nucleotides 6620 and 7200) of the sequence of Ratner et al. (32) in the env gene and a chloramphenicol acetyltransferase (CAT) gene replacing the nef gene (17, 36 (5) . The labeled cells were lysed in 10 mM Tris-HCl (pH 7.4)-150 mM NaCl-5% Triton X-114 at 0°C, and the detergent phase containing integral membrane proteins was isolated by phase separation at 30°C, dissolved in RIPA lysis buffer, clarified, and immunoprecipitated as previously described (3, 11) . Virions produced in COS-1 cells were pelleted as described above following labeling of transfected COS-1 cells for 16 (Fig. 1) , which is consistent with previous studies (9, 26, 37) . When (Fig. 4) (17) . In this assay, COS-1 cells cotransfected with an envelope expressor plasmid and an envelopedefective provirus expressing the CAT gene produce recombinant virions that are used to infect Jurkat T lymphocytes (17) . The (Fig. 5A and Table 1 ). The levels of wild-type and mutant gpl20 in the transfected COS-1 cell supernatants correlated with the levels of cell-associated gp120 (data not shown). When labeling COS-1 cells for 16 h was followed by a 3-h chase with excess cold methionine and cysteine, the levels of mutant envelope glycoproteins that were low in the steady state were further reduced ( Fig. 5B and Table 2 ). This result suggests that deletion of residues amino terminal to amino acid 846 results in decreased envelope glycoprotein stability in COS-1 cells.
The cytoplasmic domain of gp4l is not required for incorporation of envelope glycoproteins into virions. To determine whether the cytoplasmic domain of gp4l is required for the (Table 2 and Fig. 5B and C) . A virion association index was calculated to normalize the level of virion-associated gpl20 for the level of cell-associated gpl20 (Table 2) . Deletions amino terminal to residue 846 caused reductions in the level of virion-associated gpl20 to 70% or less of the wild-type level (Fig. 5C and Table 2 ). However, the virion association index of the mutant glycoproteins was similar to or greater than that of the wild-type envelope glycoproteins under conditions in which the levels of cell-associated gpl20 were similar (Table 2) . Moreover, the relative incorporation of gpl20 into virions was generally more efficient when the levels of wild-type or mutant cell-associated gpl20 were relatively low (Table 2 ). These results demonstrate that the cytoplasmic domain of gp4l is not required for the efficient incorporation of the gpl20 envelope glycoprotein into virions. It can also be inferred that the incorporation of the gp4l glycoprotein is not defective, since the cell or virus association of the gpl20 glycoprotein depends on an interaction with gp4l (24) .
To determine whether the observed decrease in the absolute amount of virion-associated mutant envelope glycoprotein was the sole cause of the replication defect in virions made in COS-1 cells, replication complementation by the wild-type and mutant envelope glycoproteins was compared under conditions in which levels of virion-associated gp120 Table 2 . Values for replication complementation were determined by using the replication complementation assay in COS-1 cells (Table 1 were similar. The relationship between the levels of virionassociated wild-type glycoprotein and degree of replication complementation was nonlinear, with saturation of the latter value when the level of virion-associated glycoprotein was only 35% of the maximum value (Fig. 6A) . As shown in Fig.  6A , relatively low levels of wild-type virion-associated envelope glycoprotein can mediate virus entry efficiently. In contrast, most mutant envelope glycoproteins containing deletions within the cytoplasmic domain exhibited a replication defect that could not be solely attributed to the reduced level of virion-associated envelope glycoproteins (Fig. 6A) .
The gp4l cytoplasmic domain is not required for syncytium formation. To determine whether a defect in fusion was the cause of the reduced replication complementation ability of the mutant envelope glycoproteins produced in COS-1 cells, COS-1 cells were cotransfected with a wild-type or mutant envelope expressor plasmid and cocultured with CD4-positive SupTl cells, and syncytium-forming ability was scored. The syncytium-forming abilities of most of the mutant glycoproteins expressed in COS-1 cells were less than those of the wild-type glycoproteins (Table 1) . Since previous studies had demonstrated that syncytium formation in other cell types did not require the cytoplasmic domain (7, 24) , the syncytium-forming abilities of the mutant envelope glycoproteins were also examined in Jurkat-tat cells (11, 18) . In Jurkat-tat cells, the syncytium-forming abilities of the mutant glycoproteins were usually equal to or greater than those of the wild-type glycoproteins (Table 1) . These results suggest either that the syncytium-forming ability of the mutant glycoproteins is dependent on the cell type in which the envelope glycoproteins are expressed or that syncytium formation in COS-1 cells might be reduced as a consequence of decreased expression of the mutant envelope glycoproteins on the cell surface.
To determine whether the decrease in syncytium formation observed in COS-1 cells could be solely attributed to reduced expression of envelope glycoproteins on the cell surface, the expression of selected mutant envelope glycoproteins on the cell surface was determined by immunoprecipitation, analysis on SDS-polyacrylamide gels, and quantitation by gel densitometry. The syncytium-forming abilities of the wild-type and mutant envelope glycoproteins were compared under conditions in which similar levels were expressed on the cell surface. For the A(726-856), A(814-856), and A(840-856) mutant glycoproteins, the level of envelope glycoproteins expressed on the cell surface was not significantly different from the wild-type level when the levels of intracellular envelope glycoproteins were similar (Table 2 and Fig. 6B) . Furthermore, the syncytium-forming abilities of the mutant envelope glycoproteins made in COS-1 cells were similar to that of wild type when similar levels of envelope glycoproteins were expressed on the cell surface (Fig. 6B ). These results demonstrate that the cytoplasmic domain is not required for the cell surface expres- Soluble-CD4 sensitivity of the mutant envelope glycoproteins. HIV-1 envelope glycoproteins that exhibit more than a twofold decrease in relative CD4-binding ability are less sensitive than the wild-type glycoprotein to soluble CD4 inhibition of virus entry (38) . To investigate the possibility that deletions in the cytoplasmic domain of gp4l affect the CD4-binding ability of the functional envelope glycoprotein multimer, the effect of mutations in the cytoplasmic domain on soluble CD4 inhibition of virus entry was examined.
Equivalent amounts of recombinant virions produced in COS-1 cells as determined by measuring reverse transcriptase activity were incubated with different concentrations of soluble CD4 for 1 h at 37°C prior to infection of Jurkat target cells. The A(814-856), A(840-856), and A(846-856) mutants exhibited the same sensitivity to soluble-CD4 inhibition of virus entry as the wild-type envelope glycoprotein (Fig. 7) . From these results, it can be inferred that deletions in the cytoplasmic domain of gp4l do not significantly alter the CD4-binding ability of the native, multimeric envelope glycoproteins. This conclusion is consistent with previous observations that alterations in the gp4l cytoplasmic domain do not affect the CD4-binding ability of the monomeric soluble form of the gpl20 glycoprotein (2, 7, 8, 24) .
DISCUSSION
This study demonstrates that the cytoplasmic domain of the HIV-1 transmembrane glycoprotein has at least two effects on viral replication. A highly conserved region within residues 840 to 856 at the carboxyl terminus of gp4l is important for efficient virus entry during an early step in the virus life cycle between CD4 binding and formation of the DNA provirus. The entire cytoplasmic domain amino terminal to residue 846 affects the stability of envelope glycoproteins made in COS-1 cells. The entire cytoplasmic domain appears to affect the efficiency of virus entry during the cell-free transmission of viruses made in COS-1 cells, whereas residues 726 to 769 are dispensable for cell-to-cell transmission in Jurkat cells. Whether these differences are a consequence of the cell type in which the envelope glycoproteins are made or reflect differences in the requirement for this domain during cell-free versus cell-to-cell transmission remains to be determined.
The reduced efficiency of HIV-1 provirus formation following acute infection with HXB2A(840-856) demonstrates that the carboxyl terminus of the HIV-1 transmembrane glycoprotein has an effect on the efficiency of virus entry during an early stage in the virus life cycle prior to formation of the provirus. The steps in the virus life cycle required for virus entry include CD4 binding, fusion of the virus and host cell membranes, and penetration and uncoating of the viral core (13) . Deletion of the carboxyl terminus of gp4l is unlikely to affect CD4 binding, since the CD4-binding domains are all contained within the gpl20 subunit (24, 27) . The lack of requirement for the cytoplasmic domain for syncytium formation and the lack of altered sensitivity to soluble CD4 provide further evidence that deletions in this region do not significantly affect the CD4-binding affinity of the multimeric glycoprotein complex. Deletions in the cytoplasmic domain of gp4l are also not likely to affect the fusion function, since this domain is not required for syncytium formation, as demonstrated here and in previous studies (7, 24) . The possibility that the membrane fusion function of only the virion-associated envelope glycoproteins is defective has not been excluded, but reliable methods for measuring the fusion function of the small fraction of virions relevant to infection are not available. The competence of the mutant envelope glycoproteins for CD4 binding and membrane fusion in conjunction with inefficient formation of the DNA provirus raises the possibility that these truncated envelope glycoproteins are defective for a step involved in the uncoating or penetration of the viral core. The location of the gp4l carboxyl terminus within the virion close to the viral core is consistent with the possibility that this region plays a role in virus uncoating or penetration.
Independent of a role in virus replication, the integrity of the gp4l cytoplasmic domain amino terminal to residue 846 is important for the stability of envelope glycoproteins expressed in COS-1 cells. The observation that the stability of gpl60 in HXB2A(840-856)-infected Jurkat cell cultures is decreased suggests that the cytoplasmic domain also has an effect on the stability of the envelope glycoproteins in other cell types. The effect of the cytoplasmic domain on envelope glycoprotein stability appears to be cell type dependent, judging by the observation that the effect is relatively minor in Jurkat cells and the finding that some mutant glycoproteins that showed decreased stability in COS-1 cells were fully functional, and thus presumably stable, in Jurkat cells. These results are consistent with previous studies demonstrating that the stability and processing of the HIV-1 envelope glycoproteins depend on the cell type in which the envelope glycoproteins are expressed (8, 18 (40) . The mechanism by which the cytoplasmic domain affects envelope glycoprotein stability is unknown. One possibility is that deletions in the cytoplasmic domain result in altered transport of gpl60, as observed in one study (16) , which might affect localization to subcellular compartments where degradation occurs.
The cytoplasmic domain of the transmembrane protein does not appear to be required for the efficient incorporation of the HIV-1 envelope glycoproteins into virions. These findings are consistent with those of previous studies demonstrating that SIV and equine infectious anemia virus containing truncated envelope glycoproteins are still infectious (4, 34) . Similar studies of deletions of the shorter cytoplasmic domain of the Rous sarcoma virus envelope glycoprotein also demonstrated that this region was dispensable for virion incorporation, although in this case, infectivity was not affected (29) . The studies reported herein, combined with systematic mutagenic analysis of the HIV-1 gp4l transmembrane region (11) , essentially eliminate the possibility that interaction of specific gp4l sequences with gag proteins is a necessary step for incorporation of envelope glycoproteins into virions. The incorporation of the HIV-1 envelope glycoproteins into virions occurred more efficiently when levels of wild-type or mutant cell-associated envelope glycoproteins were low. This result suggests that a mechanism for concentrating the envelope glycoproteins into virions is involved in HIV-1 virion assembly. Whether the cytoplasmic domain is required for another step in virus assembly is not known, but the examination of HXB2(840-856) virions by electron microscopy and determination of the rate of gag precursor processing ( Fig. 2D and E) did not reveal any gross defects in virus assembly or maturation (lla).
An HIV-1 provirus containing a 4-amino-acid deletion and an additional 15 random residues in the gp4l cytoplasmic domain, X10-1, was reported to result in a replicationcompetent HIV-1 exhibiting the ability to form syncytia but no ability to efficiently lyse single cells (9) . A subsequent study also proposed a role for the cytoplasmic domain of gp4l in viral cytopathic effects (26 (23) . The results of the present study provide further evidence that the cytoplasmic domain of gp4l does not play a major role in viral cytopathic effect independent of the effects of changes in this region on viral replication rate.
